Lung Cancer Surgery Market to Reach USD 2.64 Billion by 2035, Driven by Robotic and AI Advances

[Newark, November 2025] — The latest analysis by Future Market Insights, Inc. (FMI) projects the global lung cancer surgery market to reach USD 2.64 billion by 2035, growing at a CAGR of 5.9% from an estimated USD 1.48 billion in 2025. The growth is driven by technological innovation, early screening initiatives, and expanding access to surgical care across emerging economies.

Market Attribute Details

Estimated Global Market Size (2025E) USD 1.48 Billion

Projected Market Value (2035F) USD 2.64 Billion

Value-based CAGR (2025–2035) 5.9%

Market Overview

The lung cancer surgery industry is undergoing a transformative shift as healthcare systems globally prioritize early diagnosis, minimally invasive techniques, and robotics-driven interventions.

Advances in low-dose CT (LDCT) screening, government-funded patient assistance programs, and AI-integrated surgical imaging systems are reshaping treatment accessibility and precision.

In India, initiatives such as the Health Minister’s Cancer Patient Fund have reduced treatment barriers for low-income groups, increasing surgery uptake in tertiary hospitals. Globally, technological convergence and data-driven care are redefining how thoracic oncology is delivered — from robotic-assisted resections to real-time imaging analytics.

Explore trends before investing — request a sample report today! https://www.futuremarketinsights.com/reports/sample/rep-gb-396

Key Market Drivers

1. Rising Adoption of Robotic-Assisted Surgery

The introduction of robotic systems is revolutionizing thoracic oncology. According to Intuitive Surgical’s CEO, “Advancements in robotic-assisted thoracic procedures are redefining precision and patient recovery in oncology.”

Robotic platforms such as da Vinci systems allow surgeons enhanced dexterity and visibility, reducing complications and hospital stays. By 2035, robotic-assisted surgeries are projected to account for over 40% of all lung cancer procedures worldwide.

2. Government-Backed Screening and Awareness Programs

Public health initiatives aimed at early detection and screening are expanding the operable patient pool. Programs like the UK’s Targeted Lung Health Checks (TLHC) and Australia’s National Lung Cancer Screening Program are identifying early-stage cases where surgical intervention remains viable.

In parallel, awareness campaigns led by public figures and survivor networks are improving diagnosis rates, particularly in middle-income countries.

3. Data-Driven Care and AI Integration

Medical device companies such as Olympus Corporation are introducing AI-enhanced imaging systems that integrate with patient records. These systems tag intraoperative visuals to track long-term recovery outcomes, promoting traceable, outcome-based care — a key focus in global oncology strategies.

Market Insights by Application and End User

Segmentectomy Leads with 40.1% Market Share

Segmentectomy remains the most preferred surgical procedure, accounting for 40.1% share in 2025. It combines oncologic effectiveness with lung preservation, particularly suitable for early-stage non-small cell lung cancer (NSCLC) and high-risk patients with limited pulmonary reserve.

With continued standardization of techniques and surgeon training, the segment is expected to grow steadily at 5.5% CAGR through 2035.

Hospitals Dominate with 65% of Total Procedures

Hospitals represent 65.0% of total market demand, underscoring their dominance in infrastructure, surgical expertise, and access to advanced technology.

Comprehensive care, multidisciplinary oncology units, and government support make hospitals the primary centers for thoracic surgeries. As robotic systems become standard in tertiary centers, hospitals are expected to sustain leadership, growing at 5.8% CAGR through 2035.

Global Prevalence and Geographic Trends

Lung cancer remains one of the most prevalent cancers worldwide.

• China leads with 1.41 million cases, reflecting the world’s highest absolute burden.
• The United States follows with 288,000 cases, driven by robust detection systems.
• Japan reports 145,000 cases despite its smaller population, highlighting an aging demographic and early detection success.
• India has 114,000 cases, shaped more by population scale than screening intensity.

On a per-capita basis, Japan leads globally, followed by China, France, and Canada — each reporting more than 95 cases per 100,000 people, signaling substantial healthcare strain.

Country-Level Analysis

United States

The U.S. market is forecast to grow from USD 420 million in 2025 to USD 620 million by 2035 (4.0% CAGR), driven by strong insurance coverage, early screening programs, and high adoption of robotic-assisted surgery.

China

China is the fastest-growing market, expected to rise from USD 1.12 billion (2025) to USD 2.13 billion (2035), at 6.7% CAGR.

India

India’s market, projected at USD 0.62 billion (2025), is forecast to reach USD 1.23 billion (2035), posting the highest CAGR at 7.0%. Growth is led by private hospital expansion, government reforms under the National Medical Devices Policy (2023), and partnerships with multinational device makers to localize robotic-assisted systems.

Germany

Germany is valued at USD 0.58 billion (2025) and will reach USD 1.03 billion by 2035 (6.0% CAGR). Strong reimbursement frameworks, early screening, and widespread adoption of VATS (Video-Assisted Thoracoscopic Surgery) and RATS (Robotic-Assisted Thoracic Surgery) underpin its leadership in Europe.

United Kingdom

With USD 0.54 billion (2025) projected to reach USD 0.95 billion by 2035 (5.6% CAGR), the UK benefits from its NHS-driven care model and centralized cancer hubs.

Japan

Japan’s industry, valued at USD 0.50 billion (2025), will expand to USD 0.89 billion (2035) at 5.9% CAGR.

Brazil, Mexico, Canada, and Australia

• Brazil (6.6% CAGR): Urban centers like São Paulo lead robotic surgery adoption, supported by public-private partnerships.
• Mexico (6.7% CAGR): Regulatory reforms and new diagnostic hubs are boosting access to minimally invasive thoracic surgeries.
• Canada (6.0% CAGR): AI-enabled navigation tools and academic collaborations are improving quality outcomes under the universal healthcare system.
• Australia (6.4% CAGR): Nationwide screening and Medicare coverage drive adoption of robotic and VATS procedures across public hospitals.

Access Expert Analysis & Forecasts – Buy Now Before Prices Rise! https://www.futuremarketinsights.com/checkout/396

Competitive Landscape

The global lung cancer surgery industry is moderately consolidated, with major players focusing on robotic innovation, imaging precision, and integrated surgical systems.

Company Strategic Focus

Intuitive Surgical Inc.: Global leader in robotic-assisted thoracic surgery (da Vinci systems), holding ~24% market share.

Medtronic Plc.: Diversified surgical devices and energy instruments with global hospital partnerships.

Ethicon Inc. (Johnson & Johnson): Comprehensive surgeon training, hemostatic technologies, and stapler innovations.

Olympus Medical Systems Corp.: Leadership in thoracoscopic visualization and AI-enhanced imaging.

Karl Storz SE & Co. KG: Strong European footprint with modular endoscopic platforms.

Emerging players such as FUJIFILM Holdings, Teleflex, and Ambu A/S are leveraging smart imaging and cost-efficient designs to capture niche segments, particularly in Asia-Pacific and Latin America.

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com

Related Reports - Exploring Insights Across Emerging Global Markets:

Melatonin Sleep Supplements Market: https://www.futuremarketinsights.com/reports/melatonin-sleep-supplements-market

Addison Disease Testing Market: https://www.futuremarketinsights.com/reports/addison-disease-testing-market

Spinal Osteosynthesis Units Market https://www.futuremarketinsights.com/reports/spinal-osteosynthesis-units-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

Why FMI: Decisions that Change Outcomes

At Future Market Insights (FMI), we transform market data into actionable insights—each recommendation comes with a named owner, timeline, and KPI to ensure measurable impact. With decision-focused deliverables like tailored dashboards, scenario models, and execution playbooks, FMI empowers teams to move from analysis to growth with confidence.